NEONATAL SEIZURES
Clinical trials for NEONATAL SEIZURES explained in plain language.
Never miss a new study
Get alerted when new NEONATAL SEIZURES trials appear
Sign up with your email to follow new studies for NEONATAL SEIZURES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for newborn seizures: levetiracetam tested as First-Line treatment
Disease control CompletedThis study tested the drug levetiracetam as the first treatment for seizures in 18 full-term newborns who had brain injury from lack of oxygen at birth. The goal was to find the right dose and check if it is safe and effective at reducing seizure activity on brain recordings. The…
Matched conditions: NEONATAL SEIZURES
Phase: PHASE2 • Sponsor: University Hospital, Tours • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
New hope for newborn seizures: levetiracetam tested as safer alternative
Symptom relief CompletedThis completed trial tested whether levetiracetam works better and safer than the standard drug phenobarbitone for stopping seizures in newborns. 260 babies with seizures received either levetiracetam or phenobarbitone. Researchers measured how quickly seizures stopped and if the…
Matched conditions: NEONATAL SEIZURES
Phase: NA • Sponsor: Hayat Abad Medical Complex, Peshawar • Aim: Symptom relief
Last updated Jun 27, 2026 09:03 UTC
-
New wireless EEG monitor tested on 17 newborns
Knowledge-focused CompletedThis study tested a new portable, wireless EEG monitor called NeuroBell on 17 full-term newborns who already needed brain monitoring. The goal was to see if the new device records brain signals as well as standard EEG machines. The study did not treat any condition, but aimed to …
Matched conditions: NEONATAL SEIZURES
Sponsor: University College Cork • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:04 UTC